Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia

Shira Dinner, Daniel Lee, Michaela Liedtke*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science